Skip to search formSkip to main contentSkip to account menu

Privigen

Known as: Venimmune 
National Institutes of Health

Related topics

Related topics

4 relations
100 ML Immunoglobulin G, Human 100 MG/ML Injection [Privigen]

Broader (3)

Immunoglobulin GImmunoglobulin G, HumanImmunoglobulins, Intravenous

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Une fracture vertébrale non traumatique chez un sujet jeune conduisant au diagnostic de stiff person syndrome !
2018
2018
[Approach for identifying of treatment option for pediatric patients in Guillain-Barre syndrome considering results of pharmacoeconomic analysis].
AIM A pharmacoeconomic analysis of direct costs on treatment with high dose intravenous immunoglobulins (IVIG) and plasmapheresis… 
2009
2009
Efficacy and safety of privigen in children and adolescents with primary immunodeficiency.
The objective of this prospective, open-label, single-arm, Phase III study was to assess the efficacy and safety of Privigen… 
2009
2009
An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.
2009
2009
Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen©) stabilized with L‐proline
Background and Objectives  IgPro10 (Privigen©) is a new liquid intravenous immunoglobulin (IVIG) product that is formulated with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)